NFKB1 and COVID-19: Previous studies have found that excessive TNFα represented a poor prognosis in SARS-CoV and MERS cases,142–145 and inhibition of NF-κB improved pulmonary symptoms in SARS-CoV-infected mice.146 However, the role of TNFα in COVID-19 is, so far, still not entirely clear.